Qing Ye

4.6k total citations · 1 hit paper
75 papers, 3.5k citations indexed

About

Qing Ye is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qing Ye has authored 75 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Qing Ye's work include RNA modifications and cancer (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and MicroRNA in disease regulation (7 papers). Qing Ye is often cited by papers focused on RNA modifications and cancer (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and MicroRNA in disease regulation (7 papers). Qing Ye collaborates with scholars based in United States, China and Germany. Qing Ye's co-authors include Neal Rosen, David B. Solit, Christine A. Pratilas, Jose Lobo, Qing‐Bai She, William R. Sellers, Ayana Sawai, Andrea Basso, Iman Osman and Gad Getz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Qing Ye

70 papers receiving 3.5k citations

Hit Papers

BRAF mutation predicts sensitivity to MEK inhibition 2005 2026 2012 2019 2005 250 500 750 1000

Peers

Qing Ye
Donald Ogilvie United Kingdom
Yonghe Li United States
Iva Klevernic United Kingdom
Esther Zwick Germany
Qing Ye
Citations per year, relative to Qing Ye Qing Ye (= 1×) peers Mario Mancino

Countries citing papers authored by Qing Ye

Since Specialization
Citations

This map shows the geographic impact of Qing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Ye more than expected).

Fields of papers citing papers by Qing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Ye. The network helps show where Qing Ye may publish in the future.

Co-authorship network of co-authors of Qing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Ye. A scholar is included among the top collaborators of Qing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Ye. Qing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Chengwen, Ying Zeng, Hua Jiang, et al.. (2025). Multifocal medulloblastoma in an adult: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology. 151(5). 166–166. 1 indexed citations
2.
Chen, Yu, Xin Zhang, Qing Ye, et al.. (2024). Machine learning-based prediction model for myocardial ischemia under high altitude exposure: a cohort study. Scientific Reports. 14(1). 686–686. 1 indexed citations
3.
Ye, Qing, et al.. (2023). MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. Cells. 12(14). 1917–1917. 9 indexed citations
4.
Zhang, Zhufeng, Tao Liu, Xudong Li, et al.. (2023). Metagenome-assembled genomes reveal carbohydrate degradation and element metabolism of microorganisms inhabiting Tengchong hot springs, China. Environmental Research. 238(Pt 1). 117144–117144. 3 indexed citations
5.
Ye, Qing, et al.. (2023). MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes. Cancers. 15(8). 2294–2294. 9 indexed citations
6.
Ye, Qing, Chunyi Zhao, Qian Wu, et al.. (2022). A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma. Disease Markers. 2022. 1–11. 4 indexed citations
7.
Chen, Liding, Qing Ye, Jianqiu Chen, et al.. (2022). A fungal cellulose nanocrystals-based approach to improve the stability of triterpenes loaded Pickering emulsion. International Journal of Biological Macromolecules. 222(Pt A). 438–447. 8 indexed citations
8.
Wang, Yuming, Zhiyong Sun, Haiping Lin, et al.. (2022). Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 Axis. International Journal of Biological Sciences. 18(15). 5787–5808. 22 indexed citations
9.
Zhang, Mengwei, Zhipeng Wang, Qiqiang Zhang, et al.. (2021). Rapid Determination of Pemetrexed Concentration and Distribution in Human Breast Cancer Cells (McF-7) Based on UHPLC-MS/MS. International Journal of Analytical Chemistry. 2021. 1–8.
10.
Hu, Li, Jie Wang, Huijie Huang, et al.. (2021). YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1. American Journal of Respiratory and Critical Care Medicine. 203(9). 1158–1172. 93 indexed citations
11.
Zhang, Yu, Ziye Zhang, Lina Zhang, et al.. (2020). Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy.. PubMed. 17(3). 257–261. 1 indexed citations
12.
Ye, Qing, Qifeng Wang, Peng Qi, et al.. (2020). Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin. Journal of Molecular Diagnostics. 22(9). 1139–1150. 17 indexed citations
13.
Guo, Nancy Lan, Dhimiter Bello, Qing Ye, et al.. (2020). Pilot deep RNA sequencing of worker blood samples from Singapore printing industry for occupational risk assessment. NanoImpact. 19. 100248–100248. 11 indexed citations
14.
Goretsky, Tatiana, Emily Bradford, Qing Ye, et al.. (2018). Beta-catenin cleavage enhances transcriptional activation. Scientific Reports. 8(1). 671–671. 24 indexed citations
15.
Xiong, Wei, Yiqin Ai, Qing Ye, et al.. (2017). Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells. BioMed Research International. 2017. 1–8. 71 indexed citations
17.
Pu, Xiaohong, Jiong Shi, Zhiwen Li, An‐Ning Feng, & Qing Ye. (2014). Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer. Pathology - Research and Practice. 211(6). 421–425. 25 indexed citations
18.
Halilovic, Ensar, Qing‐Bai She, Qing Ye, et al.. (2010). PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling. Cancer Research. 70(17). 6804–6814. 133 indexed citations
19.
Pratilas, Christine A., Barry S. Taylor, Qing Ye, et al.. (2009). V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway. Proceedings of the National Academy of Sciences. 106(11). 4519–4524. 455 indexed citations
20.
Chandarlapaty, Sarat, Ayana Sawai, Qing Ye, et al.. (2008). SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers. Clinical Cancer Research. 14(1). 240–248. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026